Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
  1. 4 Grant or award Director acquired 54,500 shares (grant or award)
  2. 4 Open-market sale Vargeese Chandra sold 1,500 shares at $35.00 ($52,500)
  3. 4 Open-market buy Director bought 423,398 shares at an average $23.34 ($9,881,550)
  4. 4 Open-market sale Director sold 20,747 shares at an average $24.21 ($502,301)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Franchise Lead, Neurology sold 7,414 shares at $16.67 ($123,620)
  12. 4 Open-market sale Director sold 433,825 shares at $24.91 ($10,806,581)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Vargeese Chandra acquired 9,800 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 4,300 shares (grant or award)
  17. 4 Grant or award Director acquired 36,300 shares (grant or award)
  18. 4 Grant or award Head of Neurology Franchise acquired 6,900 shares (grant or award)
  19. 4 Grant or award Francis Chris acquired 9,800 shares (grant or award)
  20. 4 Exercise or conversion GUERCIOLINI ROBERTO acquired 24,000 shares (option exercise)

Page 12 of 14 · 274 filings